This became significantly disrupted upon PFF inoculation, with 17.8% of pS129 α-synuclein subsequently contained in the SDS fraction in brain regions exhibiting moderate synucleinopathy, which rose to 30.1% in regions exhibiting severe pS129 α-synuclein pathology (Fig. 5f). This evidence concerns the gene SNCA and synucleinopathy.